Harvard Bioscience (HBIO) Competitors

Harvard Bioscience (NASDAQ:HBIO) and Thermo Fisher Scientific (NYSE:TMO) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, valuation, analyst recommendations, risk, media sentiment, earnings, dividends, community ranking and institutional ownership.

Is HBIO or TMO more profitable?

Thermo Fisher Scientific has a net margin of 14.78% compared to Harvard Bioscience's net margin of -14.57%. Thermo Fisher Scientific's return on equity of 17.51% beat Harvard Bioscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Harvard Bioscience	-14.57%	-4.64%	-2.40%
Thermo Fisher Scientific	14.78%	17.51%	8.52%

Do analysts rate HBIO or TMO?

Harvard Bioscience presently has a consensus target price of $4.50, suggesting a potential upside of 1,013.86%. Thermo Fisher Scientific has a consensus target price of $647.43, suggesting a potential upside of 45.98%. Given Harvard Bioscience's higher probable upside, equities analysts clearly believe Harvard Bioscience is more favorable than Thermo Fisher Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Harvard Bioscience	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Thermo Fisher Scientific	0 Sell rating(s)	4 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.81

Do insiders and institutionals hold more shares of HBIO or TMO?

80.9% of Harvard Bioscience shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 9.0% of Harvard Bioscience shares are held by company insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Which has more volatility and risk, HBIO or TMO?

Harvard Bioscience has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500.

Does the media prefer HBIO or TMO?

In the previous week, Thermo Fisher Scientific had 47 more articles in the media than Harvard Bioscience. MarketBeat recorded 58 mentions for Thermo Fisher Scientific and 11 mentions for Harvard Bioscience. Thermo Fisher Scientific's average media sentiment score of 1.33 beat Harvard Bioscience's score of -0.02 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Harvard Bioscience	1 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Thermo Fisher Scientific	44 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has preferable earnings and valuation, HBIO or TMO?

Thermo Fisher Scientific has higher revenue and earnings than Harvard Bioscience. Harvard Bioscience is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Harvard Bioscience	$94.14M	0.19	-$3.41M	-$0.29	-1.39
Thermo Fisher Scientific	$42.88B	3.90	$6.34B	$16.53	26.83

Does the MarketBeat Community favor HBIO or TMO?

Thermo Fisher Scientific received 714 more outperform votes than Harvard Bioscience when rated by MarketBeat users. Likewise, 80.76% of users gave Thermo Fisher Scientific an outperform vote while only 71.79% of users gave Harvard Bioscience an outperform vote.

Company	Underperform	Outperform
Harvard Bioscience	Outperform Votes 369 71.79%	Underperform Votes 145 28.21%
Thermo Fisher Scientific	Outperform Votes 1083 80.76%	Underperform Votes 258 19.24%

Summary

Thermo Fisher Scientific beats Harvard Bioscience on 15 of the 18 factors compared between the two stocks.